GlassScriptPhysician profile
Michael Seem
NPI 1336594621
$35,131.28
in general payments reported to CMS, 2019-2025
9 companies · $3,237 in 2025
The $3,237 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11K · 2022: $14K · 2023: $2,455 · 2024: $4,056 · 2025: $3,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,056 · Food and Beverage: $3,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,056.42 |
| Food and Beverage | $3,691.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,093.14 | 2021-2023 | Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $8,129.61 | 2022-2025 | Persona, Avenir, Rosa |
| Stryker Corporation | $3,810.30 | 2021-2025 | Mako, Triathlon, 1788 |
| Medical Device Business Services, INC. | $1,304.96 | 2022 | |
| Medtronic, INC. | $1,079.92 | 2023 | Aquamantys(Tm) |
| Depuy Synthes Sales INC. | $481.33 | 2021-2024 | Attune, Actis, Velys |
| Total Joint Orthopedics, INC. | $186.44 | 2021-2022 | |
| Nuvasive, INC. | $29.94 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Seem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.